Australia markets closed

Control Bionics Limited (CBL.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.0490-0.0040 (-7.55%)
At close: 10:42AM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.02
52-week change 3-44.79%
S&P500 52-week change 326.36%
52-week high 30.0960
52-week low 30.0370
50-day moving average 30.0590
200-day moving average 30.0590

Share statistics

Avg vol (3-month) 322.21k
Avg vol (10-day) 322.21k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 849.76M
% held by insiders 169.13%
% held by institutions 112.94%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -84.45%
Operating margin (ttm)-70.71%

Management effectiveness

Return on assets (ttm)-28.64%
Return on equity (ttm)-55.33%

Income statement

Revenue (ttm)5.71M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)2.30%
Gross profit (ttm)N/A
EBITDA -4.11M
Net income avi to common (ttm)-4.82M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.31M
Total cash per share (mrq)0.01
Total debt (mrq)78.71k
Total debt/equity (mrq)1.02%
Current ratio (mrq)3.34
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-3.81M
Levered free cash flow (ttm)-2.43M